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Abstract
Background: End-of-life care has become an issue of great clinical and public health concern. From analyses of
official death certificates, we have societal knowledge on how many people die, at what age, where and from what
causes. However, we know little about how people are dying. There is a lack of population-based and nationwide
data that evaluate and monitor the circumstances of death and the care received in the final months of life. The
present study was designed to describe the places of end-of-life care and care transitions, the caregivers involved
in patient care and the actual treatments and care provided to dying patients in Belgium. The patient, residence
and healthcare characteristics associated with these aspects of end-of-life care provision will also be studied. In
this report, the protocol of the study is outlined.
Methods/Design: We designed a nationwide mortality follow-back study with data collection in 2005 and 2006,
via the nationwide Belgian Sentinel Network of General Practitioners (GPs) i.e. an existing epidemiological
surveillance system representative of all GPs in Belgium, covering 1.75% of the total Belgian population. All GPs
were asked to report weekly, on a standardized registration form, every patient (>1 year) in their practice who
had died, and to identify patients who had died "non-suddenly." The last three months of these patients' lives were
surveyed retrospectively. Several quality control measures were used to ensure data of high scientific quality.
Discussion: In 2005 and 2006, respectively 1385 and 1305 deaths were identified of which 66% and 63% died
non-suddenly. The first results are expected in 2007. Via this study, we will build a descriptive epidemiological
database on end-of-life care provision in Belgium, which might serve as baseline measurement to monitor end-of-
life care over time. The study will inform medical practice as well as healthcare authorities in setting up an end-
of-life care policy. We publish the protocol here to inform others, in particular countries with analogue GP
surveillance networks, on the possibilities of performing end-of-life care research. A preliminary analysis of the
possible strengths, weaknesses and opportunities of our research is outlined.
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Background
End-of-life care has become an issue of great clinical and
public health importance and concern. Developments
contributing to this are the growing number of elderly
people, the increasingly chronic nature of dying in devel-
oped societies, the accompanying rise in health care costs,
and the growing recognition that end-of-life care is less
than optimal in many countries [1-4].
However, there is a lack of population-based and nation-
wide data that evaluate and monitor how and in what cir-
cumstances people are dying and what care they are
receiving in the final months of life [3-6]. From the anal-
ysis of mortality statistics based on official death certifica-
tion, we have learned how many people die, at what age,
from what causes, and where e.g. [7], but no such system-
atic nationwide data are being gathered concerning the
(quality of) end-of-life care. Several efforts have been
made to explore data relevant for end-of-life care in exist-
ing large-scale databases such as disease registries or
healthcare billing data, and newly developed population-
based surveys have shed light on important aspects of
quality in end-of-life care, mainly in the UK and US [8-
14]. But several basic population-based descriptions of
how end-of-life care is organised for all dying patients in
a whole country, are lacking on an international level [1-
6]. Important gaps in knowledge include: (1) who takes
care of the dying, how often are specialized multidiscipli-
nary palliative care teams involved and which factors
affect their involvement; (2) how much time is spent in
different care settings at the end of life and how often are
patients transferred between care settings at the end of life;
(3) what type of care is provided to patients at the end of
life: what are the main goals of medical treatment, and
how often is patient care focused at palliative care as rec-
ommended by the World Health Organisation [1,2]?
Almost all earlier studies are restricted to specific popula-
tions of patients (such as cancer or elderly patients) or to
specific settings (such as nursing homes, hospices or hos-
pitals), have small sample sizes or focused on a specific
aspect of end-of-life care provision, thus providing only a
limited view on how people are dying in a society [11,15-
26].
The absence of this basic epidemiological information
hampers the ability to develop an effective public health
policy on end-of-life care. Gathering epidemiological data
on the places of care, the caregivers involved, and the
actual care given is pivotal to the rational planning, organ-
isation, and implementation of healthcare services for the
dying and an important first step towards improving end-
of-life care.
Specifically for Belgium, end-of-life care research has pri-
marily been focused on euthanasia and other end-of-life
decisions [27,28], while further empirical knowledge on
the provision of end-of-life care is scarce. This contrasts
sharply with the societal and political attention to "end-
of-life-issues," considering its recently approved laws on
palliative care, patient rights and euthanasia (2002) [29-
31].
This "SENTI-MELC study" (Sentinel Network study Mon-
itoring End-of-Life Care) is the first nationwide, popula-
tion-based study on end-of-life care provision in Belgium.
For the purpose of measuring across patient populations
and care settings, we explored the possibilities of using an
existing surveillance network, namely the Belgian Sentinel
Network of General Practitioners.
Aims of the study
The over-riding objectives of this SENTI-MELC study are:
1) To map out the places of care and death, and the care
setting trajectory of patients at the end of life
2) To describe the caregivers involved in end-of-life care,
and the actual treatments and care provided at the end of
life; and more specifically to study the role of the general
practitioner and of specialized multidisciplinary palliative
care services
3) To study the patient, residence, and healthcare charac-
teristics associated with places of care, caregivers, and end-
of-life care provided.
The objective of this report is to present the protocol of
the study used for the data collection in 2005 and 2006.
We hope that our experience in Belgium will be useful to
others, in particular to countries with analogue surveil-
lance networks of general practitioners [32,33] who wish
to initiate end-of-life care research into their registrations.
The described methodology will also serve as detailed ref-
erence for the method section of future SENTI-MELC pub-
lications as results from the study emerge.
Methods/Design
Because of the problems with prognosticating who is
dying, it is difficult, if not impossible, to obtain informa-
tion from a representative sample of dying patients in pro-
spective end-of-life care research [34,35]. Therefore, a
retrospective nationwide mortality follow-back survey,
with data collection shortly after the patient had died, was
chosen for this study.
Observational unit
General practice is highly accessible in Belgium: almost all
of the population (95%), including care home residents,BMC Palliative Care 2007, 6:6 http://www.biomedcentral.com/1472-684X/6/6
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have a regular general practitioner (GP) who they consult
regularly [36]. Hence, GPs can provide a good public
health perspective on end-of-life care and dying in the
country and it would be possible to generate a popula-
tion-based sample of deaths via GPs. Therefore, we
decided to work with a representative sample of GPs in
Belgium.
A Sentinel Network of General Practitioners is a network
of practices or community based physicians who monitor
one, several or an exhaustive list of health problems on a
regular or continuing basis. The information from these
practices is used to monitor the health of the entire popu-
lation [32,37]. The Belgian Sentinel Network of GPs is a
nationwide network, operational since 1979, and has
proved to be a reliable surveillance system for a wide vari-
ety of health-related epidemiological data e.g. on diabe-
tes, stroke, cancer, accidents [33,38-43].
The GPs in the Network collect data via continuous and
weekly paper-and-pencil registrations using a standard-
ized registration form. Each registration programme lasts
minimally one year. Each year, about 8 different themes
are surveyed. The general objectives of a Sentinel Network
of GPs are: to evaluate public health problems and their
importance within the general population; to continu-
ously observe certain health problems over time for exam-
ple to study the impact of prevention campaigns; and to
study the management and follow-up of health problems
by the general practitioners. Recorded data must concern
an important health problem not subject to surveillance
of another system, unless the Sentinel Network provides
complementary information to this end. The participa-
tion of the GPs is voluntary. Feedback is regularly distrib-
uted to the participants, concerned authorities, the
medical press, scientific associations and interested indi-
viduals. The turnover of the GPs, from year to year, is low,
which contributes to the collection of data of high scien-
tific quality. Also, only regularly participating GPs (i.e.
who register at least 26 weeks per year) are included for
data analyses. The Sentinel Network is funded by the
regional governments of Belgium and co-ordinated by the
Scientific Institute of Public Health [44].
In 2005, the first year of this study, the Network consisted
of 181 regularly participating GP practices (205 GPs),
who were representative of all 10,578 GPs in Belgium in
terms of age, gender and geographical distribution, and
also of the GPs in the Northern (Dutch-speaking) and
Southern (French-speaking) regions of Belgium sepa-
rately. The Network covered 1.75% of the total Belgian
population [40,44].
Study population
The unit of measurement in this study was the death case.
Primary inclusion criteria were:
- every patient, part of the practice of the GP, who had
died (certified deaths and deaths of which they were
informed afterwards)
- aged one year or older
In order to focus this study on care delivered at the end of
life or on dying patients (i.e. patients who were theoreti-
cally able to receive care in the terminal phase of life) we
additionally excluded all deaths that had occurred "sud-
denly and totally unexpectedly [28,45]."
Retrospective data collection procedure
For the purpose of this study, the GPs registered deaths on
a weekly standardized registration form, during 2 consec-
utive years (2005–2006) from January 1st until December
31st. To shorten the time between death and registration –
hence preventing recall bias as much as possible – the
physicians were instructed to register all deaths, immedi-
ately after being informed about the patient's death. GPs
use patient records and information coming from hospi-
tal physicians as much as possible when filling in the
forms. To control for possible non-response (e.g. GPs who
forgot to report one of their deaths), all GPs received a
summary of all reported deaths after each year of registra-
tion. GPs were asked to verify all these reported deaths
and indicate if there were deaths that were not yet
reported. If this was the case, we asked about basic demo-
graphic information (age, sex, place and cause of death) of
the unreported deaths.
Definition of concepts
In this study, the terminal phase under consideration was
defined as the last three months of life of patients that
died non-suddenly [34,46-48].
Transitions between end-of-life care settings were defined as
moves or changes in location of care, during the last three
months of life. Home (or with relatives, in service flats),
care home (elderly/nursing home), hospital and (inpa-
tient) palliative care unit, were differentiated. Care setting
trajectories are a combination of moves between different
settings.
Caregivers involved in patient care were subdivided into
informal caregivers (e.g. partner, child, sibling, friends)
and formal caregivers (specialized multidisciplinary palli-
ative care services, GP, clinical specialist, nurse, caretaker/
home carer, spiritual caregiver, physio-, occupational-,
speech therapist).BMC Palliative Care 2007, 6:6 http://www.biomedcentral.com/1472-684X/6/6
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End-of-life care was measured in terms of end-of-life care
goals i.e. main treatment aim (cure, prolonging life, or
palliative/comfort/supportive care), specific potentially
life-prolonging and palliative treatments received, and
physical, psychosocial and/or spiritual content of care
[1,2]. Other end-of-life practices measured were the
absence/presence of continuous deep sedation until death
of the patient, and of medical end-of-life decisions with
possible life-shortening effect i.e. (1) non-treatment deci-
sions; (2) alleviation of pain or other symptoms, in dos-
ages which are large enough to include the hastening of
death as a possible or certain side-effect; and (3) physi-
cian-assisted dying (including euthanasia, physician-
assisted suicide, and life-ending without the patient's
explicit request). This categorisation was based on a pre-
existing internationally validated framework [27,28,49].
Measurement instrument
To develop the registration form for this study, we selected
instruments used in other (Dutch) retrospective and
quantitative studies whenever possible [17,27,28,50-54].
In case a specific concept could not be measured with an
existing instrument, questions were developed on the
basis of relevant literature and in dialogue with the Bel-
gian Scientific Institute of Public Health (coordinating the
Sentinel Network of GPs) and with a counselling project
Advisory Board consisting of 5 MDs (of which 4 GPs), a
palliative care physician, 2 psychologists, a medical soci-
ologist, a health scientist, an anthropologist and a repre-
sentative from a home care nursing organisation. We also
copied questions from the official death certificates in Bel-
gium, in order to optimize comparison afterwards.
Because Belgium consists of two large regions in which
Dutch or French is spoken, the instrument was first devel-
oped in Dutch and then translated into French via for-
ward-backward procedure.
The standardized weekly registration form is shown in
Additional File 1 in English (forward translation from the
Dutch version). The first part A concerned several patient-
and residence characteristics and was filled in for all
patients who met the primary inclusion criteria. Ques-
tions from Part A based on official death certificates were
Q2, Q3, Q4, Q5, Q8, Q10, Q11 and Q12. Question 17
was taken from previously designed questionnaires in Bel-
gium and the Netherlands [27,28,45]. Questions
designed in dialogue with the Scientific Institute of Public
Health and the counselling Advisory Board were Q6, Q7,
Q9, Q13, Q14, Q15 and Q16.
For all patients who had died non-suddenly, the GPs reg-
istered part B consisting of: places of care and wishes for
place of death, the caregivers involved during the last
three months of life, the (goals of) end-of-life care and
medical decision-making. Several aspects of the medical
care provided were measured using three separate time
frames: last week, second to fourth week and second to
third month before death. Questions from Part B based
on previously designed questionnaires in Belgium and the
Netherlands [17,27,28,50-54] were Q3, Q4, Q5 (partly),
Q6 and Q9 until Q16. Literature concerning life-sustain-
ing therapies and indicators of aggressive and palliative
care [11,21,55-58] additionally guided the development
of Q5. Questions designed in the counselling Advisory
Board were Q1, Q2, Q7 and Q8.
The quantitative registration instrument implied that all
items had closed-ended response options. Also, in order
to avoid the confounding effect that positive or negative
connotations of several terms may or may not have (for
example euthanasia or terminal sedation), we only used
wording that describes the actual medical practices.
Finally, GPs were sent accompanying instructions at the
beginning of each year, clearly stating the inclusion crite-
ria of the study, and clarifying the manner in which the
questions concerning cause of death and care setting tra-
jectory needed to be filled in.
Ethical considerations
The Scientific Institute of Public Health, co-ordinating the
Belgian Sentinel Network of GPs, asks the GPs to give writ-
ten informed consent at the beginning of each year, after
being fully informed about the objectives and method of
the research themes. The registration of deaths is part of
this procedure.
Furthermore, strict procedures regarding patient anonym-
ity are employed [59]. Every patient that is registered
within the network receives an anonymous reference from
the GP him/herself. An independent "Trust Service Pro-
vider" is responsible for supplementary anonymisation of
patient information i.e. the patient's date of birth is regis-
tered by the GP but replaced with the patient's age before
data-entry, and postal code of habitual residence is trans-
formed into more aggregate indicators such as province
and region of care. Concerning the GPs' identity, all his/
her identification codes are replaced in the data files with
anonymous codes during data cleaning.
The protocol of the present study was approved by the
Ethical Review Board of Brussels University Hospital of
the Vrije Universiteit Brussel (2004).
Pilot study
The feasibility of the study design and the measurement
instruments have been tested in an extensive pilot study of
3 months in 2004 [60]. The pilot study was also intended
to estimate the number of non-sudden deaths that GPsBMC Palliative Care 2007, 6:6 http://www.biomedcentral.com/1472-684X/6/6
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would register per year, and the statistical power for the
analyses of the main study in 2005 and 2006. The physi-
cians were instructed to register all deaths of patients, aged
one year or older, on a continuous basis during the
months of inclusion (13 consecutive weeks), as well as the
last death before this period.
In 2004, 176 GP practices reported one or more deaths. In
total 502 deaths were reported, of which 466 were part of
the GPs' practices. Patients who were not part of the GPs'
practices (whose death was certified by the GP) were
excluded. Sixty-eight percent (n = 318) of this group died
during the inclusion period, and 62% (n = 214) of the lat-
ter group had died non-suddenly.
On the basis of this pilot study, the registration instru-
ment was slightly adapted. It was estimated that 1310
patients who were part of the GPs' practices would be reg-
istered in 2005 by the 181 participating practices, and that
890 of these patients would have died non-suddenly.
Data management and plan of statistical analysis
Several control measures are used to ensure data quality
and to limit missing data. Data are entered weekly using a
dbase-based programme. Range and skip checks prevent
key-punching errors. Automatic follow-up of missing data
for key variables and a consistency check during data-
entry with the possibility of contacting GPs by phone,
improve data quality. Key-punch errors are corrected via
double data-entry.
Data cleaning and data analyses for this study are per-
formed using SPSS14.0 (SPPS Inc). During data cleaning,
no manual changes are made. Instead, all operations are
stored via SPPS syntax-files to create a working data file.
Databases are stored with a central data manager at the
Scientific Institute of Public Health. To answer the first
two descriptive objectives of the study concerning the
places of care, and medical care provided, we plan to use
mainly descriptive statistics i.e. valid percentages and 95%
Confidence Intervals. To study the characteristics associ-
ated with these outcome measures (objective 3), we will
use multivariate logistic regression analyses.
To verify if a representative population-based sample of
deaths can be obtained via this representative sample of
GPs, we will evaluate whether the deaths registered by the
Sentinel Network of GPs are comparable in terms of age,
sex, place of death and cause of death, to the deaths occur-
ring within the general population (using bivariate and
multivariate statistics). Since there are no recent mortality
statistics available for the Southern Region of Belgium, the
comparison will be made only for the data from the
Northern and Brussels Capital Region (66% of the total
population).
Discussion
The objectives of this nationwide study are to describe
end-of-life care provided to patients who had died non-
suddenly in Belgium, and to investigate patient, disease
and healthcare characteristics associated with variations
in end-of-life care. To realize these objectives, a mortality
follow-back study with data collection via the Belgian
Sentinel Network of General Practitioners was set up.
From the participating GP practices, a total of 1385
patients had died between January 1st and December 31st
2005. Thirty-four percent was judged to have died sud-
denly and totally unexpectedly. From January through
December 2006, a total of 1305 patients had died, of
which 37% suddenly and totally unexpectedly. Using the
Sentinel Network of GPs, we obtained a percentage of
sudden deaths, analogue to that reported in previous
nationwide studies on end-of-life decisions based on the
"death certificate sampling" design [28]. The first results
of the SENTI-MELC study are expected in 2007 [61].
This study has several potential strengths as well as limita-
tions associated with the use of an existing surveillance
network of GPs in general, and with the specific design of
the study.
Strengths
The Belgian Sentinel Network of General Practitioners is
representative of all GPs in Belgium, has a long tradition
in scientific research (operational since 1979), is very flex-
ible in terms of acceptability of new registrations, and is
very stable in terms of participating GPs. The GPs are
highly motivated to monitor various health-related prob-
lems over long and repeated periods, thus have not been
selected on the basis of a specific interest in end-of-life
research. Because detailed information concerning the
care provided is not always available from the patients'
medical files, a registration directly with GPs has an
important surplus value. Since general practice is highly
accessible in Belgium, a representative sample of the
entire population can be monitored. Comparisons
between the national vital statistics and the (age- and sex-
specific) incidences of stroke mortality and suicide regis-
tered via this Sentinel Network, and between several
national and international cancer registries and the cancer
incidence registered via this Sentinel Network, have
shown that the Sentinel Network can provide information
representative for the whole population of Belgium
[38,62-64].
A specific strength of this mortality follow-back study
itself is that retrospective recall bias found in other retro-
spective research designs [28,35], will be limited, because
of the weekly registrations, leaving little time between
death and registration. Also, identification of non-suddenBMC Palliative Care 2007, 6:6 http://www.biomedcentral.com/1472-684X/6/6
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deaths as denominator is an advantage over other pro-
spective and retrospective designs that have been criti-
cized for selecting patients solely on the basis of diagnose
or cause of death. Not all patients with a cancer diagnose,
for example, also die of cancer or receive care with an end-
of-life intent [34,47,65]. By avoiding to include patients
that died suddenly and unexpectedly, we will be able to
study care that was truly delivered in the context of a dying
process. On the basis of literature, we judged the last three
months of life as a relevant study period [34,46-48].
Weaknesses
The surveillance system also has several weaknesses.
Because in Belgium, there are no patient lists per practice,
the population denominator (the "sentinel population")
is not precisely defined and has to be estimated on the
basis of annual total number of patient encounters in the
participating practices [40]. Also, the registration form is
to be kept simple, and time-consuming questions should
be avoided in a surveillance system. Consequently, in-
depth study of some aspects of care is generally not possi-
ble via this type of registration research [32,43].
Possible weaknesses of the mortality study are the retro-
spective data collection approach making reconstruction
of all care provided in the final three months of life diffi-
cult [35] and the reliance on GPs to report care and deci-
sions at the end of life, including care delivered to patients
in hospitals or decisions taken by hospital physicians. An
underestimation of specific types of care provided or deci-
sions taken is thus possible. The extent of this problem
will be studied in detail.
Opportunities for further research
Firstly, while data gathering with the Sentinel Network in
2005–2006 focused on the processes of care delivered, a
similar data gathering with the same network has been set
up, aimed at investigating outcomes of quality of end-of-
life care and at developing quality indicators. Data will be
gathered from 2007 until 2009. Secondly, because data
can be gathered over time, we will, in the long-run, evalu-
ate the monitoring potential of this instrument. The
results could potentially serve as baseline data to monitor
end-of-life care over time. Thirdly, a study with Sentinel
Networks creates important opportunities for interna-
tional comparative research. Most European countries
have at least one sentinel network of GPs [32,33,37]. The
death registration that was started up in Belgium in 2005
has also been implemented in the Netherlands, and other
European countries (Italy, Switzerland, Spain) are cur-
rently investigating if analogue studies are possible.
In conclusion, societal knowledge concerning the end of
life has been limited to place and causes of death. Addi-
tionally, and for the first time in Belgium, with the SENTI-
MELC study, we will build a public health database on
how people are dying and what care they are receiving at
the end of life. It will be possible to make practice and
healthcare policy recommendations on the basis of this
information.
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